Cochrane Abstracts
Fulvestrant for hormone‐sensitive metastatic breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fulvestrant for Hormone‐sensitive Metastatic Breast Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439206/all/Fulvestrant_for_hormone‐sensitive_metastatic_breast_cancer.
Fulvestrant for hormone‐sensitive metastatic breast cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439206/all/Fulvestrant_for_hormone‐sensitive_metastatic_breast_cancer. Accessed March 18, 2025.
Fulvestrant for hormone‐sensitive metastatic breast cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439206/all/Fulvestrant_for_hormone‐sensitive_metastatic_breast_cancer
Fulvestrant for Hormone‐sensitive Metastatic Breast Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439206/all/Fulvestrant_for_hormone‐sensitive_metastatic_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fulvestrant for hormone‐sensitive metastatic breast cancer
ID - 439206
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439206/all/Fulvestrant_for_hormone‐sensitive_metastatic_breast_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
